logo-loader
viewCellmid Limited

Cellmid notches up strong Japanese TV shopping sales with revenue of $1.19 million

The revenue result is an improvement on the prior TSV events in June 2019 as well as in December 2019.

Cellmid is an Australian life sciences company with a consumer health business and biotech assets
Cellmid is an Australian life sciences company with a consumer health business and biotech assets

Cellmid Ltd (ASX:CDY) has received a strong response to a sales event for its Jo-Ju® branded consumer products on Japanese television shopping channel QVC with wholesale revenue of $1.19 million.

The result from the Today’s Special Value (TSV) event was slightly higher than the $1.14 million achieved on the TSV event in June 2019 and higher than the last TSV event in December 2019 of $1.13 million.

Cellmid's consumer health products are now sold on television shopping channels QVC Germany and QVC US and on Openshop in Australia, in addition to QVC Japan.

“Outstanding sales result”

Chief executive officer Maria Halasz said: “We are pleased to report such an outstanding sales result for our Japanese Jo-Ju® branded products, especially under adverse economic conditions due to the COVID-19 pandemic.

“We have implemented operational efficiencies, opened new sales channels and product lines in the past few months, which we expect will impact favourably on our results in FY2020 and beyond.”

Cellmid’s consumer health business, Advangen, delivered $7.34 million revenue in FY2019 and the company has since been broadening distribution channels and improving business efficiencies.

With economies affected by COVID-19 now reopening in the key markets of Japan, Australia, USA and China, the company is well-placed to improve its performance going forward.

Best performing sales channel

Television shopping remains the best performing sales channel for Cellmid’s products.

Sales in Australia through Openshop (channel 75) have been gradually increasing since the launch in October 2019.

Cellmid also launched its évolis® Professional products on QVC Germany in March and QVC USA in May 2020.

Consistent with previous years, over 80% of the company’s revenue is expected to come from its consumer business in FY2020.

Quick facts: Cellmid Limited

Price: 0.115 AUD

ASX:CDY
Market: ASX
Market Cap: $14.4 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cellmid Limited to supply rapid diagnostic tests to help in new pandemic

Cellmid Limited (ASX:CDY) CEO Maria Halasz tells Proactive's Andrew Scott they've signed an agreement to supply rapid diagnostic tests (RDT), with products expected to arrive in the country by early April. The test uses a virus-specific detection method that delivers results anywhere between...

on 30/3/20

2 min read